» Articles » PMID: 20967581

Isolation of Low-n Amyloid β-protein Oligomers from Cultured Cells, CSF, and Brain

Overview
Specialty Molecular Biology
Date 2010 Oct 23
PMID 20967581
Citations 40
Authors
Affiliations
Soon will be listed here.
Abstract

Recent data suggest that soluble, non-fibrillar assemblies of the amyloid β-protein (Aβ) may mediate the synaptic deficits that characterize the early stages of Alzheimer's disease. Consequently, much effort has been expended in isolating and studying a variety of different Aβ assemblies. Here, we describe the use of immunoprecipitation/western blotting and size exclusion chromatography/western blotting to characterize Aβ present in conditioned medium from cultured cells, human cerebrospinal fluid, and human cortex extracted with aqueous buffer, detergent, and formic acid.

Citing Articles

Alzheimer's disease linked Aβ42 exerts product feedback inhibition on γ-secretase impairing downstream cell signaling.

Zoltowska K, Das U, Lismont S, Enzlein T, Maesako M, Houser M Elife. 2024; 12.

PMID: 39027984 PMC: 11259434. DOI: 10.7554/eLife.90690.


Long-term normalization of calcineurin activity in model mice rescues Pin1 and attenuates Alzheimer's phenotypes without blocking peripheral T cell IL-2 response.

Stallings N, ONeal M, Hu J, Shen Z, Malter J Alzheimers Res Ther. 2023; 15(1):179.

PMID: 37849016 PMC: 10580561. DOI: 10.1186/s13195-023-01323-5.


Alzheimer's disease linked Aβ42 exerts product feedback inhibition on γ-secretase impairing downstream cell signaling.

Zoltowska K, Das U, Lismont S, Enzlein T, Maesako M, Houser M bioRxiv. 2023; .

PMID: 37577527 PMC: 10418207. DOI: 10.1101/2023.08.02.551596.


Activation of β-adrenergic receptors prevents AD-type synaptotoxicity via epigenetic mechanisms.

Jin M, Wei Z, Ramalingam N, Xiao M, Xu A, Yu X Mol Psychiatry. 2023; 28(11):4877-4888.

PMID: 37365243 DOI: 10.1038/s41380-023-02145-5.


3D bioengineered neural tissue generated from patient-derived iPSCs mimics time-dependent phenotypes and transcriptional features of Alzheimer's disease.

Lomoio S, Pandey R, Rouleau N, Menicacci B, Kim W, Cantley W Mol Psychiatry. 2023; 28(12):5390-5401.

PMID: 37365240 PMC: 11164539. DOI: 10.1038/s41380-023-02147-3.